Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 245 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mineralization Clear all

Conditions: Obesity, Osteoporosis
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 40 Years and older · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Burn, Growth, Malnutrition
Interventions: Calcium,Vitamin D, Calcium, VitaminD, Sugar Pill; Dietary Supplement · Other
Lead sponsor: Kathy Prelack, PhD, RD; Other
Eligibility: 4 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Psychiatry
Interventions: Not listed
Lead sponsor: Creighton University; Other
Eligibility: 11 Years to 17 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Osteoporosis
Interventions: Not listed
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 7 Years to 40 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Bone Loss, Osteoporosis, Breast Cancer
Interventions: risedronate; Drug
Lead sponsor: Susan L. Greenspan; Other
Eligibility: 55 Years and older · Female only
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Osteoporosis, Frailty
Interventions: DHEA, Yoga, Placebo, Aerobics; Dietary Supplement · Behavioral
Lead sponsor: National Aeronautics and Space Administration (NASA); Federal
Eligibility: 65 Years and older · Female only
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Bone Mineral Density Reference Data
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Year to 5 Years
Enrollment: 484 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: Cincinnati, Ohio • Philadelphia, Pennsylvania

Conditions: Hip Fracture
Interventions: Exercise Plus Program; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 65 Years and older · Female only
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2005
U.S. locations: 3
States / cities: Baltimore, Maryland • Randallstown, Maryland • Towson, Maryland

Conditions: Breast Neoplasms
Interventions: Exemestane, Calcium carbonate, Vitamin D; Drug · Dietary Supplement
Lead sponsor: Georgetown University; Other
Eligibility: Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Osteopenic Women
Interventions: 2 POMx Capsules, 2 placebo Capsules; Dietary Supplement
Lead sponsor: POM Wonderful LLC; Industry
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Physical Activity, Nutrition
Interventions: Physical activity, Calcium supplement; Procedure · Drug
Lead sponsor: South Dakota State University; Other
Eligibility: 3 Years to 4 Years
Enrollment: 224 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2003
U.S. locations: 1
States / cities: Brookings, South Dakota

Conditions: Osteoporosis
Interventions: No intervention element, observational study.; Other
Lead sponsor: Drexel University; Other
Eligibility: 20 Years to 50 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bone Density, Cancer
Interventions: Not listed
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Osteoporosis, Osteopenia
Interventions: Calcium carbonate, Calcium Phosphate; Drug
Lead sponsor: Creighton University; Other
Eligibility: 60 Years to 85 Years · Female only
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Osteopenia
Interventions: Lunar Prodigy (GEHC), Lunar iDXA (GEHC), Discovery A (Hologic; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 20 Years and older
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Lakewood, Colorado

Conditions: Low Bone Mass, Osteoporosis, Postmenopausal
Interventions: DHEA, Placebo, Exercise; Other · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 55 Years to 85 Years · Female only
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Age-Related Osteoporosis
Interventions: Sample collection for gene expression; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 85 Years
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Bone Mineral Density, Hemophilia A, Hemophilia B
Interventions: DXA scan + MRI; Other
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 25 Years and older · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Regional Osteoporosis as a Result of Chemotherapy
Interventions: DXA Scan; Radiation
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 16 Years to 40 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Spinal Cord Injury, Spinal Cord Injuries, Injuries, Spinal Cord, Spinal Cord Contusion, Spinal Cord Trauma, Trauma, Nervous System, Wounds and Injuries, Spinal Cord Compression, Nervous System Diseases, Spinal Cord Diseases, Gonadal Disorders, Endocrine System Diseases, Hypogonadism, Genital Diseases, Male
Interventions: testosterone cypionate, finasteride, placebo injection, placebo pill; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 4
States / cities: Aurora, Colorado • Gainesville, Florida • Tampa, Florida + 1 more

Conditions: Epilepsy, Bone Loss, Osteoporosis, Fractures
Interventions: Risedronate, Placebo + Calcium and Vitamin D; Drug
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 18 Years to 85 Years · Male only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Menstrual Irregularity
Interventions: EAMD+Calories; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 233 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Hyperparathyroidism, Secondary
Interventions: Etelcalcetide; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 40
States / cities: Alhambra, California • Azusa, California • Bakersfield, California + 37 more

Conditions: Lupus Erythematosus, Systemic
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 7 Years to 22 Years
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Bone Metabolism After Bariatric Surgery

Bone Mineral Density, Body Composition and Growth Following Severe Burn Injury

Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents

Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric Cancers

Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy

Effects of DHEA/Exercise on Bone, Muscle and Balance

Bone Mineral Accretion in Young Children

BHS4 - Bone/Muscle Changes Following Hip Fracture in Older White Women

Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer

Pomegranate Extract Biomarker Study in Osteopenic Women

Physical Activity, Calcium, and Bone in Children

Determinants of Bone Mineral Density and Metabolic Syndrome in South Asian Indian Men

Screening of Bone Mineral Density in Women Who Have Received Chemotherapy

Adding Phosphorus to Osteoporosis Drug Treatment

DXA Precision and Accuracy Comparison Study

DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women

Genetic Regulators of Bone Health That Are Unique to Vertebral Bone

Osteoporosis and MRI Study in Hemophilia

Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers

Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial

Antiepileptic Drugs and Osteoporotic Prevention Trial

Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus